Literature DB >> 24174359

Acute-phase reactants and cytokines in ischemic stroke: do they have any relationship with short-term mortality?

M Sahan1, A Sebe, A Acikalin, O Akpinar, F Koc, M O Ay, M Gulen, M Topal, S Satar.   

Abstract

BACKGROUND: Many unknown risk factors play a role in the etiopathogenesis of stroke. The appearance of inflammatory cells within the damaged tissue after cerebral ischemia suggests that an inflammatory response may play a role in stroke pathogenesis. In our study, we examined whether an association exists between the acute-phase reactants and the levels of cytokines, the volume and diameter of the stroke, and short-term mortality in patients who were diagnosed as acute ischemic a stroke after admission to the Emergency Department. PATIENTS AND METHODS: A total of 50 consecutive patients who applied to the Emergency Service with acute ischemic stroke were enrolled in the study. Their stroke volume were calculated and serum samples were obtained as soon as they arrived into the Emergency Service. The patients were evaluated according to the Glasgow Coma Scale (GCS) and National Institutes of Health Stroke Scale (NIHSS).
RESULTS: There was no significant correlations between stroke volume and levels of cytokine and acute-phase reactants in dead patient group or in living patient group. A correlation and statistical significance was found between stroke volume and hospital stay time in living patient group. In addition, GCS and NIHSS scores were correlated with stroke volume and was found a significant statistically.
CONCLUSIONS: Scales such as GKS and NIHHS, which evaluate the functional state of patients, are the best indicators for defining prognosis in our daily practices. In addition, we found a positive correlation between levels of CRP (C reactive protein) and prognosis. However, we did not observe a statistically significant correlation between prognosis and other acute-phase reactants such as TNF-alpha, IL-6, IL-8, IL-10, fibrinogen, and leukocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24174359

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  High-sensitivity C-reactive protein, lipoprotein-related phospholipase A2, and acute ischemic stroke.

Authors:  Hasan Kara; Murat Akinci; Selim Degirmenci; Aysegul Bayir; Ahmet Ak; Alaaddin Nayman; Ali Unlu; Fikret Akyurek; Mesut Sivri
Journal:  Neuropsychiatr Dis Treat       Date:  2014-08-06       Impact factor: 2.570

2.  Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension.

Authors:  Danhong Wu; Yi Lyu; Ping Zhong; Fengdi Liu; Xueyuan Liu
Journal:  Brain Behav       Date:  2017-06-21       Impact factor: 2.708

Review 3.  Role of Interleukin-10 in Acute Brain Injuries.

Authors:  Joshua M Garcia; Stephanie A Stillings; Jenna L Leclerc; Harrison Phillips; Nancy J Edwards; Steven A Robicsek; Brian L Hoh; Spiros Blackburn; Sylvain Doré
Journal:  Front Neurol       Date:  2017-06-12       Impact factor: 4.003

Review 4.  Inflammatory molecules might become both biomarkers and therapeutic targets for stroke management.

Authors:  Laura Ramiro; Alba Simats; Teresa García-Berrocoso; Joan Montaner
Journal:  Ther Adv Neurol Disord       Date:  2018-08-06       Impact factor: 6.570

5.  A cross-sectional study to assess the association between major depression and inflammatory markers in patients with acute ischemic stroke.

Authors:  Hasan Hüseyin Kozak; Faruk Uğuz; İbrahim Kılınç; Ali Ulvi Uca; Osman Serhat Tokgöz; Figen Güney; Nejla Özer
Journal:  Indian J Psychiatry       Date:  2019 May-Jun       Impact factor: 1.759

Review 6.  Human urinary kallidinogenase combined with edaravone in treating acute ischemic stroke patients: A meta-analysis.

Authors:  Di-Xiao Yang; Yao Li; Dan Yu; Bi Guan; Qian Ming; Yan Li; Li-Qing Chen
Journal:  Brain Behav       Date:  2021-11-22       Impact factor: 2.708

7.  Ability of serum C-reactive protein and white blood cell cout in predicting acute schemic stroke. A short -term follow-up study.

Authors:  Babak Bakhshayesh-Eghbali; Seyed-Ali Roudbary; Seddigheh Basir Jafari; Seyedeh-Parand Nabizadeh; Naghmeh Naderi-Asrami; Reza Sohrabnejad
Journal:  Caspian J Intern Med       Date:  2016

8.  Effect of HUK on the outcome of ruptured intracranial aneurysm.

Authors:  Luyue Chen; Yi Lyu; Xiaoning Lin; Minghui Sun; Wei Feng; Xinhua Tian
Journal:  Brain Behav       Date:  2018-08-29       Impact factor: 2.708

9.  Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery.

Authors:  Dong Han; Xin Chen; Dongmei Li; Shuang Liu; Yi Lyu; Juan Feng
Journal:  Brain Behav       Date:  2018-07-20       Impact factor: 2.708

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.